Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (29) Blankenstein, Thomas Prof. Dr. (21) Bunse, Mario Dr. (1) Harabula, Izabela-Cezara (1) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lupianez Garcia, Dario Jesus Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (5) (-) Fischer, Cornelius Dr. (1) (-) Kammertöns, Thomas Dr. (8) Bioinformatik der Genregulation (1) Experimentelle Ultrahochfeld-MR (7) Genetik metabolischer und reproduktiver Störungen (1) Genom-Editierung & Krankheitsmodelle (2) (-) Genomics (1) Immunregulation und Krebs (3) Kardiale MRT (1) Magnetic Resonance (7) (-) Molekulare Immunologie und Gentherapie (8) Proteom Dynamik (2) RNA Biologie und Posttranscriptionale Regulation (3) Transgenics (2) Tumorgenetik und zelluläre Stressantworten (1) Zelluläre Neurowissenschaften (2) 1998 (1) 1999 (1) 2000 (3) 2001 (1) 2003 (1) 2004 (3) 2005 (3) 2007 (1) 2009 (3) 2010 (1) 2011 (2) (-) 2012 (3) (-) 2013 (4) 2015 (2) (-) 2016 (2) 2017 (2) 2018 (3) 2019 (5) 2020 (8) 2021 (1) 2022 (10) 2024 (1) 9 Ergebnisse: Active Filter: Fischer, Cornelius Dr.Kammertöns, Thomas Dr.GenomicsMolekulare Immunologie und Gentherapie 201220132016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein 01. Mai 2013 / Canc Res Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens J Zhang L Chen X Liu T. Kammertoens T. Blankenstein Z. Qin 01. Oktober 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein 15. April 2013 / Canc Cell It's the peptide-MHC affinity, stupid T. Kammertoens T. Blankenstein 30. März 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm 07. Oktober 2016 / J Proteome Res Efficient application of de novo RNA assemblers for proteomics informed by transcriptomics T. Luge C. Fischer S. Sauer 01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein 01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya
05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
01. Mai 2013 / Canc Res Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens J Zhang L Chen X Liu T. Kammertoens T. Blankenstein Z. Qin
01. Oktober 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein
30. März 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm
07. Oktober 2016 / J Proteome Res Efficient application of de novo RNA assemblers for proteomics informed by transcriptomics T. Luge C. Fischer S. Sauer
01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya